×

Clinical trial management

Grayline Clinical Drug Trials

http://www.graylinecdt.com

Founded in 1986, Grayline Clinical Drug Trials is a full-service contract research site dedicated to providing clinical trials management and support to pharmaceutical companies for Phase I - IV clinical trials under FDA review. Today, Grayline is recognized as a premiere clinical trials research facility. The company and its staff bring to each clinical trial project a formidable body of experience and expertise. That collective experience covers a wide range of research designs, targeted illnesses, patient populations, and recruitment strategies. Our multi-disciplinary staff includes physicians, information technology specialists, certified clinical research coordinators, data managers, data entry specialists, and quality control directors. Dedicated to meeting and exceeding the objectives and requirements of our sponsors, Grayline Clinical Drug Trials adheres to the highest industry standards and processes. We emphasize a team approach that combines technology and experience with regulatory understanding and commitment to excellence.

  • 12/8/2013
  • 15
  • 0

Advanced Clinical Research Inc

http://www.acr-research.com

Advanced Clinical Research has specialized in conducting community-based clinical research since 1984 and has extensive knowledge in a variety of therapeutic areas. ACR has managed over 600 clinical studies and enrolled more than 6,000 patients. Corporate headquarters are located in Salt Lake City, Utah with a satellite location in Boise, Idaho. ACR's vast therapeutic experience includes the following indications: Cardiology, Dermatology, Ear Nose & Throat, Endocrinology, Infectious Disease, Internal Medicine, Neurology, Ophthalmology, Orthopaedics/Surgery, Pain Management, Pediatrics, Psychology, Urology, Vaccines (all types and age groups), Vascular/Cardiovascular and Women's Health. ACR works closely with community physicians who partner with ACR on clinical trials. ACR's principal investigators average 10 years of clinical research experience. These investigators conduct patient visits at ACR's research centers or in their own clinics, and pride themselves in being very active in the studies they are conducting. ACR is HIPPA compliant with a team of dedicated study coordinators located onsite, formal comprehensive training programs, computerized patient databases, actively involved investigators, strong experience with electronic data capture and patient diary/drug accountability products. We also have standardized internal quality assurance programs and rapid regulatory document submission including the ability to utilize central IRBs.

  • 12/8/2013
  • 16
  • 0

Synergos , Inc.

http://www.synergosinc.com

Welcome to SYNERGOS, a Contract Research Organization that provides comprehensive clinical research and development services, from study design through regulatory submission. Founded in 1991, we have substantial experience in pharmaceuticals, medical devices, and biotechnology product development, with significant expertise in numerous therapeutic and diagnostic areas. To date, we have managed, analyzed, and produced reports for each type of regulatory submission required by the FDA, including multiple NDAs and PMAs.

  • 12/8/2013
  • 18
  • 0

Allied Research International Inc.

http://www.allied-research.com

Allied Research International (ARI), a member of Cetero Research, has been in operation since 1989. As part of a family with 3 other clinical and bioanalytical companies (PRACS Institute, Gateway Medical Research, and Ba Research), we are one of the world's leading providers of early stage, bioanalytical and niche late stage clinical research services to the life sciences industry. ARI was founded by Dr. Piyush Patel, CEO and Principal Scientist and Mrs. Arti Patel, President and Physician Network Manager. ARI's foundations were built from Dr. Patel's work as a principal investigator in allergy/asthma clinical research. In 1999, Paul Benninger, Chief Operations Officer at ARI, joined the company and opened a 76-bed clinical pharmacology unit with 12 employees. To support our early phase clinical services, ARI added a bioanalytical laboratory in 2002. Building on our success in single-center trial management, ARI expanded the repertoire of services in 2005 to include planning, managing and monitoring multi-center trials in Phases II through IV of the drug development process. Combining his experience in clinical research and his specialization in allergy and clinical immunology, Dr. Patel refined the existing clinical models in allergy research and built ARI's first Environmental Exposure Chamber (EEC) in 2001. This 121-seat EEC is custom designed to conduct allergen exposure studies at any time of the year, independent of the traditional allergy seasons. With the success of the first EEC, ARI increased its R&D efforts in developing more clinical models and built its second EEC in 2004. Today, as part of Cetero Research, ARI continues to pursue scientific excellence. We are committed to research and development of the EEC technology. Our scientists are actively innovating clinical models for respiratory, immunology, and ophthalmic therapeutic areas. The opening of the 137-bed clinical pharmacology unit in Miami, USA in spring 2006 marked ARI's growth into the US market. In fall of 2006, ARI established a Central Laboratory, completed with state-of-the-art instrumentation in support of our expanding clinical services. ARI was acquired by Cetero Research on March 20, 2007. ARI is now part of a family of other clinical and bioanalytical research specialists. More than ever, ARI is focused and committed to research and scientific excellence. Contact us today to find out how you can leverage on our experience and expertise to accelerate your drug development plan.

  • 12/8/2013
  • 16
  • 0

Endpoint Research Ltd.

http://www.endpointresearch.com

Endpoint Research is a full service Clinical Research Organization founded in 1990. We provide Phase I to IV clinical development services to pharmaceutical, biotechnology and medical device companies in most major therapeutic areas, with a strength in complex indications, particularly oncology and respiratory. Endpoint has been an international CRO since 1998 when we opened our office in the United Kingdom. We have continued to expand our geographic reach and service offerings by opening our US office and implementing full, Oracle Clinical-based clinical data management, Medical and Consulting services. Our head office is in Toronto, Canada with operational offices in Houston, Texas and Bells Hill, Scotland. Endpoint provides full clinical trial services (study design, management, monitoring, data handling and statistical services) for clinical trials in North America and Europe, including Eastern Europe. Endpoint Research provides clinical research services from Phase I to regulatory submission. We have very strong capabilities in two therapeutic areas in particular:

  • 12/8/2013
  • 14
  • 0

Note

Not found any data